Orange County, California-based National Cardio Labs LLC has finalized a settlement with the government to pay $3.6 million to resolve allegations that the company knowingly submitted false claims for heart monitoring services.
In a newly unsealed suit under the False Claims Act, a fellow surgeon has alleged that his colleagues at Chicago’s prestigious Rush University Medical Center routinely overbooked their schedules and relied on residents to perform surgeries in violation of federal Medicare billing rules.
Advanced BioNutrition Corporation, of Columbia, Maryland, and its former chief executive officer, David Kyle, paid the federal government $934,000, stemming from violations of the False Claims Act, federal prosecutors said Thursday. Advanced BioNutrition Corporation was awarded the first phase of a National Science Foundation Small Business Innovation Research grant in February 2005 to develop technology to micro-encapsulate probiotic bacteria into particles.
The Health Alliance of Greater Cincinnati, two of its member hospitals (The Fort Hamilton Hospital and The University Hospital), and University Internal Medicine Associates Inc. have agreed to pay the United States $2.
A New York dermatologist settled a false claim lawsuit against him for $2.75 million. The physician was able to collect higher reimbursements from Medicaid by classifying himself as a primary care physician instead of as a dermatologist, allowing him to collect fees for services not actually provided.
More information can be found at: http://online.wsj.com/article/BT-CO-20100610-711174.
The Office of Inspector General is seeking new powers from Congress to exclude offending corporate executives from Medicare if their companies committed healthcare fraud. Under current law, OIG can only seek to bar executives from working for the companies that committed fraud. However, they are still able to work for other companies in the healthcare industry.
Cochlear America, a manufacturer of cochlear implants, has settled a false claims case against it, alleging that it made illegal payments to health care providers to induce the purchase of its implant systems. Cochlear implants are small, complex electronic devices that can help to provide a sense of sound to a person who is profoundly deaf or severely hard-of-hearing.
Johnson and Johnson filed a motion to dismiss a lawsuit against it under the False Claims Act for allegedly paying kickbacks to Omnicare, Inc to push Johnson & Johnson drugs to nursing home patients. Omnicare earlier settled a lawsuit against it for $98 million for accepting such kickbacks, although Omnicare denied liability.
If you are aware of any person, corporation or entity that you think may be violating the Federal False Claims Act or a State False Claims Act, contact us today.